U.S. FDA makes changes for device and emergency use authorizations

07/30/2013 | Clinica

The U.S. FDA will provide a single submission number for investigational device exemptions and emergency use authorizations beginning Aug. 18, which will allow the agency to track multiple studies and milestones more efficiently and will streamline the entire process. Subsequent submissions to an IDE or EUA will be assigned to the appropriate study and will be classified as supplements, reports or amendments. Under the new system, companies should ensure that they include only one submission reason per IDE submission

View Full Article in:

Clinica

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC